Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Chubb
Deloitte
Covington
QuintilesIMS
Healthtrust
Harvard Business School
Teva

Generated: April 20, 2018

DrugPatentWatch Database Preview

Metrizamide - Generic Drug Details

« Back to Dashboard

What are the generic sources for metrizamide and what is the scope of metrizamide freedom to operate?

Metrizamide
is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for metrizamide.
Summary for metrizamide
Medical Subject Heading (MeSH) Categories for metrizamide
Synonyms for metrizamide
112M626
2-((3-(Acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoyl)amino)-2-deoxy-D-glucose
2-({3-(acetylamino)-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoyl}amino)-2-deoxyhexopyranose
2-[({3-(acetylamino)-5-[acetyl(methyl)amino]-2,4,6-triiodophenyl}carbonyl)amino]-2-deoxy-D-glucopyranose
2-[[3-(Acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoyl]amino]-2-deoxy-D-glucose
3-acetamido-2,4,6-triiodo-5-(N-methylacetamido)-N-((3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)benzamide
3-acetamido-2,4,6-triiodo-5-(N-methylacetamido)-N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-N-[(2R,4S,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-N-[(2S,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)-3-oxanyl]benzamide
3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-N-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
31112-62-6
55134-11-7
AB00513843
AB00513843_06
AC1L1UBG
AC1L7W80
AC1L9FG6
AC1O8PWV
AC1Q4PLU
AKOS015965061
AKOS024370375
Amipak
Amipaque
Amipaque (TN)
API0000654
BPBio1_000624
BSPBio_000566
C18H22I3N3O8
CA003293
CAS-31112-62-6
CCG-220463
CHEBI:31841
CHEBI:91720
CHEBI:95168
CHEMBL1200889
CHEMBL462394
CS-W000133
D01311
D02VCJ
DSSTox_CID_3310
DSSTox_GSID_23310
DSSTox_RID_76969
DTXSID1023310
FT-0628934
HMS1569M08
HMS2096M08
HMS2230M07
HMS3373J14
J-018245
LS-71668
MCULE-2362596754
MCULE-7568554111
Metrizamide (JAN/USAN/INN)
Metrizamide [USAN:BAN:INN:JAN]
MFCD00010577
MLS002153823
MolPort-000-698-998
N-(5-(acetylamino)-2,4,6-triiodo-3-{N-[2,4,5-trihydroxy-6-(hydroxymethyl)(2H-3 ,4,5,6-tetrahydropyran-3-yl)]carbamoyl}phenyl)-N-methylacetamide
NCGC00016805-01
NCGC00179520-01
NSC-379419
NSC379419
OR256364
Prestwick_583
Prestwick0_000463
Prestwick1_000463
Prestwick2_000463
Prestwick3_000463
SCHEMBL1650311
SCHEMBL16984723
SCHEMBL24382
SMR001233191
SPBio_002505
SR-01000841219
SR-01000841219-2
ST51005955
STOCK1N-16357
Telebrix
Telebrix 300
Tox21_110619
WIN-39103
ZINC85540244

US Patents and Regulatory Information for metrizamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare AMIPAQUE metrizamide INJECTABLE;INJECTION 017982-003 Sep 12, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ge Healthcare AMIPAQUE metrizamide INJECTABLE;INJECTION 017982-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ge Healthcare AMIPAQUE metrizamide INJECTABLE;INJECTION 017982-004 Sep 12, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ge Healthcare AMIPAQUE metrizamide INJECTABLE;INJECTION 017982-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for metrizamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare AMIPAQUE metrizamide INJECTABLE;INJECTION 017982-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ge Healthcare AMIPAQUE metrizamide INJECTABLE;INJECTION 017982-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Dow
QuintilesIMS
Boehringer Ingelheim
Cipla
Medtronic
Colorcon
Citi
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.